The first doses of the vaccine developed by Astrazeneca arrive in France this Saturday.

At the microphone of Europe 1, François-René Pruvot, president of the medical commission of the Lille University Hospital, is delighted with this new step, which "will reassure everyone" in hospitals. 

The Covid-19 vaccination campaign continues, against a backdrop of still limited supplies and logistical constraints.

From this weekend, doses of the third vaccine available in the European Union, that of AstraZeneca, will be injected - the decree was published in the

Official Journal

on

Saturday.

"273,600 doses will be distributed from today between 117 establishments including seven in Overseas", indicated the Ministry of Health.

The vaccine will begin to be administered as a priority to caregivers under the age of 65, its effectiveness not being proven in the elderly.

For François-René Pruvot, president of the medical commission of the Lille University Hospital, this new stage "is a very great opportunity for all hospital workers."

LIVE -

 Coronavirus: follow the evolution of the situation Saturday February 6 

"Contamination exists, so it will reassure everyone"

"It is the possibility, even under 50, to be vaccinated", he rejoices at the microphone of Europe 1, recalling that the Pfizer vaccine, administered in France since the beginning of January, is still limited to the oldest .

"It will reduce the tension, stress and anxiety that some caregivers had of not being vaccinated because they were very young or were 40 years old, while they are potentially in contact with Covid patients", predicts François -René Pruvot. 

Protect yourself from possible Covid patients, therefore, but also from colleagues who declare contamination late or who are asymptomatic, continues the president of the medical committee of the Lille University Hospital.

Including in hospitals, "contamination exists, so that will reassure everyone." 

>> Find the mid-day weekend podcast and replay here 

Also, the vaccination of nursing staff will reduce the risk of cluster formation.

"These are small epidemic foci that we would like to avoid because they are strategic. They can impose, if not to close an activity, to hinder considerably", recalls François-René Pruvot.